Cargando…
The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH
The lncRNA HOTAIR is a critical regulator of cancer progression. Chromatin remodeling factor LSH is critical for normal development of plants and mammals. However, the underlying mechanisms causing this in cancer are not entirely clear. The functional diversification of the FOXA1 and FOXA2 contribut...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675985/ https://www.ncbi.nlm.nih.gov/pubmed/26658322 http://dx.doi.org/10.1038/srep17826 |
_version_ | 1782405087129239552 |
---|---|
author | Wang, Ranran Shi, Ying Chen, Ling Jiang, Yiqun Mao, Chao Yan, Bin Liu, Shuang Shan, Bin Tao, Yongguang Wang, Xiang |
author_facet | Wang, Ranran Shi, Ying Chen, Ling Jiang, Yiqun Mao, Chao Yan, Bin Liu, Shuang Shan, Bin Tao, Yongguang Wang, Xiang |
author_sort | Wang, Ranran |
collection | PubMed |
description | The lncRNA HOTAIR is a critical regulator of cancer progression. Chromatin remodeling factor LSH is critical for normal development of plants and mammals. However, the underlying mechanisms causing this in cancer are not entirely clear. The functional diversification of the FOXA1 and FOXA2 contributes to the target genes during evolution and carcinogenesis. Little is known about the ratio of FOXA1 to FOXA2 in cancer. We here found that both HOTAIR and LSH overexpression was significantly correlated with poor survival in patients with lung adenocarcinoma cancer (ADC). Also, the ratio of FOXA1 and FOXA2 is linked with poor survival in patients with lung ADC. HOTAIR regulates the ratio of FOXA1 to FOXA2 and migration and invasion. HOTAIR and the ratio of FOXA1 to FOXA2 are negatively correlated. HOTAIR knockdown inhibits migration and invasion. HOTAIR is associated with LSH, and this association linked with the binding of LSH in the promoter of FOXA1, not FOXA2. Targeted inhibition of HOTAIR suppresses the migratory and invasive properties. These data suggest that HOTAIR is an important mediator of the ratio of FOXA1 and FOXA2 and LSH involves in, and suggest that HOTAIR inhibition may represent a promising therapeutic option for suppressing lung ADC progression. |
format | Online Article Text |
id | pubmed-4675985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46759852015-12-16 The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH Wang, Ranran Shi, Ying Chen, Ling Jiang, Yiqun Mao, Chao Yan, Bin Liu, Shuang Shan, Bin Tao, Yongguang Wang, Xiang Sci Rep Article The lncRNA HOTAIR is a critical regulator of cancer progression. Chromatin remodeling factor LSH is critical for normal development of plants and mammals. However, the underlying mechanisms causing this in cancer are not entirely clear. The functional diversification of the FOXA1 and FOXA2 contributes to the target genes during evolution and carcinogenesis. Little is known about the ratio of FOXA1 to FOXA2 in cancer. We here found that both HOTAIR and LSH overexpression was significantly correlated with poor survival in patients with lung adenocarcinoma cancer (ADC). Also, the ratio of FOXA1 and FOXA2 is linked with poor survival in patients with lung ADC. HOTAIR regulates the ratio of FOXA1 to FOXA2 and migration and invasion. HOTAIR and the ratio of FOXA1 to FOXA2 are negatively correlated. HOTAIR knockdown inhibits migration and invasion. HOTAIR is associated with LSH, and this association linked with the binding of LSH in the promoter of FOXA1, not FOXA2. Targeted inhibition of HOTAIR suppresses the migratory and invasive properties. These data suggest that HOTAIR is an important mediator of the ratio of FOXA1 and FOXA2 and LSH involves in, and suggest that HOTAIR inhibition may represent a promising therapeutic option for suppressing lung ADC progression. Nature Publishing Group 2015-12-11 /pmc/articles/PMC4675985/ /pubmed/26658322 http://dx.doi.org/10.1038/srep17826 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Wang, Ranran Shi, Ying Chen, Ling Jiang, Yiqun Mao, Chao Yan, Bin Liu, Shuang Shan, Bin Tao, Yongguang Wang, Xiang The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH |
title | The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH |
title_full | The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH |
title_fullStr | The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH |
title_full_unstemmed | The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH |
title_short | The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH |
title_sort | ratio of foxa1 to foxa2 in lung adenocarcinoma is regulated by lncrna hotair and chromatin remodeling factor lsh |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675985/ https://www.ncbi.nlm.nih.gov/pubmed/26658322 http://dx.doi.org/10.1038/srep17826 |
work_keys_str_mv | AT wangranran theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT shiying theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT chenling theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT jiangyiqun theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT maochao theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT yanbin theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT liushuang theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT shanbin theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT taoyongguang theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT wangxiang theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT wangranran ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT shiying ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT chenling ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT jiangyiqun ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT maochao ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT yanbin ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT liushuang ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT shanbin ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT taoyongguang ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh AT wangxiang ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh |